Una Ryan Talks About Biopharma Industry In Massachusetts
Dr. Una Ryan is the President of the Massachusetts Biotech Council and
the CEO of Avant Immunotherapeutics, a publicly traded
biopharmaceutical company developing vaccines and immunotherapeutics
for cardiac surgery, cholesterol management, address packed room
at Cambridge Marriott on April 18, 2006. Being an excellent speaker she
very clearly presented the prospects of Biopharma industry.
The last 10 years have seen a massive transformation of the biotech and
pharmaceuticals industry in Massachusetts. From the shores of Cambridge
stretching out across the state, the landscape is now dotted with
leading biopharma companies such as Abbott, AstraZeneca, Merck,
Novartis, and Pfizer. Massachusetts is also now the home to 280 biotech
companies. Biopharma has become a critical economic engine for the
state, generating high paying jobs that have accounted for over 50% of
the net job growth in the state in the past decade.
Ryan described the difficulties of running a Biotech company. “ It is
difficult to run a company than to start,” said Ryan. It takes
12-15 years and about 1 billion dollars to bring one drug to market.
She emphasized on spending the money wisely, which is difficult
than raising the money.
Wearing the hat of the President of Mass Biotech Council she outlined
the benefits of setting biopharma industry in Massachusetts.
Massachusetts has about 300 biopharma companies employing more than
30,000 people. It has 200 medical devices companies employing
21,000. 84 drugs and devices have been developed in Massachusetts
and has very well established supply chain.
Dr. Ryan has been Chief Executive Officer of AVANT since August 1996
and President, Chief Operating Officer and a director of AVANT since
May 1996. Dr. Ryan joined AVANT as Vice President, Research and Chief
Scientific Officer in May 1993. She is also Research Professor of
Medicine at the Whitaker Cardiovascular Institute of the Boston
University School of Medicine. Prior to joining AVANT, Dr. Ryan was
Director of Health Sciences at Monsanto Company from January 1990 to
November 1992 and Research Professor of Surgery, Medicine and Cell
Biology at Washington University School of Medicine from 1990 to 1993.
Dr. Ryan is a member of the Governing Body of Biotechnology Industry
Organization's (BIO) Emerging Companies Section and serves on the Board
of BIO and the Massachusetts Biotechnology Council. Dr. Ryan is a
member of the Board of Associates at the Whitehead Institute for
Biomedical Research and is currently a director of IQuum, Inc. In 2002,
Dr. Ryan was awarded with the Order of the British Empire (O.B.E.) for
her services to research, development and promotion of biotechnology by
Her Majesty, Queen Elizabeth the Second.
For upcoming information on TiE events visit http://boston.tie.org/
You may also access this article through our web-site http://www.lokvani.com/